Vivos (RDGL) EBIT Growth (3y) (2013 - 2025)
Vivos (RDGL) EBIT Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 13.06% |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | -15.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.80% |
| Sep 30, 2025 | -24.22% |
| Jun 30, 2025 | 5.02% |
| Mar 31, 2025 | -4.93% |
| Dec 31, 2024 | -44.70% |
| Sep 30, 2024 | -63.03% |
| Jun 30, 2024 | 34.44% |
| Mar 31, 2024 | -34.90% |
| Dec 31, 2023 | -47.26% |
| Sep 30, 2023 | -74.94% |
| Jun 30, 2023 | -92.37% |
| Mar 31, 2023 | -27.30% |
| Dec 31, 2022 | -29.55% |
| Sep 30, 2022 | 23.01% |
| Jun 30, 2022 | -65.73% |
| Mar 31, 2022 | -49.17% |
| Dec 31, 2021 | 49.77% |
| Sep 30, 2021 | -12.43% |
| Jun 30, 2021 | -75.68% |
| Mar 31, 2021 | 6.40% |